<DOC>
	<DOCNO>NCT00670332</DOCNO>
	<brief_summary>This study demonstrate whether patient prognostically-significant myocardial abnormality detect AI-700 contrast ECHO rate cardiac death MI high patient normal AI-700 contrast ECHO .</brief_summary>
	<brief_title>Prognostic Assessment Contrast Echocardiography ( PACE Study )</brief_title>
	<detailed_description>This observational study investigate ability AI-700 contrast ECHO predict risk future cardiovascular event occur patient recent history chest pain time ECHO evaluation . Eligible patient enrol either AI-700-32 AI-700-33 , complete Phase 3 international , multicenter , open-label , dual-injection study myocardial image capability safety AI-700 administer intravenously patient chest pain . In course Phase 3 study , patient evaluate AI-700 contrast ECHO . In addition , eligible patient evaluable pharmacologic stress-induced AI-700 ECHO assessment part AI-700-32 AI-700-33 .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Eligible patient enrol either AI70032 AI70033 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>echocardiography</keyword>
	<keyword>cardiac imaging</keyword>
	<keyword>heart disease</keyword>
	<keyword>ultrasound contrast agent</keyword>
	<keyword>prognosis</keyword>
</DOC>